Consolidated Balance Sheets - USD ($)	Dec. 31, 2021	Dec. 31, 2020
Current assets
Cash and cash equivalents	$ 4,015,128
Marketable securities, at fair value	5,933,364
Accounts receivable, net	30,714	30,714
Other receivables	34,965	108,815
Inventory	224,155	203,011
Prepaid expenses	186,056
Total current assets	10,424,382	342,540
Other assets
Property and equipment, net	265,267	337,241
Other assets	50,488	14,262
Total assets	10,740,137	694,043
Current liabilities
Accounts payable	871,364	861,840
Accrued expenses	311,405	123,639
Loan payable - related party		26,000
Non-convertible promissory notes – current portion	1,375,000
Total current liabilities	2,557,769	1,011,479
Non-current liabilities
Convertible notes		1,105,000
Non-convertible promissory notes – net of current portion		2,431,730
Total non-current liabilities		3,536,730
Total liabilities	2,557,769	4,548,209
Commitments and contingencies (Note 14)
Stockholders’ equity (deficit)
Preferred stock, $0.00001 par value; 20,000,000 shares authorized; 0 and 5,791,665 shares issued and outstanding as of December 31, 2021 and 2020, respectively		58
Common stock, $0.00001 par value; 80,000,000 shares authorized; 11,886,379 and 4,864,862 shares issued and outstanding as of December 31, 2021 and 2020, respectively	119	49
Additional paid-in capital	22,596,100	6,856,020
Accumulated deficit	(14,413,851)	(10,710,293)
Total stockholders’ equity (deficit)	8,182,368	(3,854,166)
Total liabilities and stockholders’ equity (deficit)	$ 10,740,137	$ 694,043